A study published in Psychiatry Research identifies subtle differences in facial shapes that may be linked to the diagnosis of schizophrenia and bipolar disorder.
Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021. Caplyta can be ...
Yes, a head injury can increase the chance of developing schizophrenia and bipolar disorder. In some cases, injury to your brain’s frontal lobe area can lead to temporary psychosis symptoms.